Zusammenfassung
Chronisch-entzündliche Erkrankungen sind charakterisiert durch das Auftreten von Sauerstoffmangel (Hypoxie) und die dadurch bedingte/notwendige zelluläre Adaptation über den hypoxieinduzierbaren Faktor (HIF). Die Modulation dieser Adaptationsmechanismen bildet die Basis für Ideen zur Wirkungsverbesserung bekannter Medikamente und für die Entwicklung neuer therapeutischer Ansatzpunkte.
Abstract
Chronic inflammatory diseases are characterized by hypoxia and subsequent cellular adaptation via hypoxia-inducible factor (HIF). Modulation of these adaptation mechanisms provides the basis for ideas on how to improve the effects of known drugs and for the development of novel therapeutic approaches.
Literatur
Dang EV, Barbi J, Yang HY et al (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146:772–784
Gaber T, Dziurla R, Tripmacher R et al (2005) Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann Rheum Dis 64:971–980
Gaber T, Schellmann S, Erekul KB et al (2011) Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+T cell proliferation under hypoxia. J Immunol 186:764–774
Hahne M, Luetkecosmann S, Tran CL et al (2010) Angiogenic potential of HMECs is driven by HIF-2α overcoming the effects of HIF-1α. Arthritis Rheum 62(Suppl 10):1418
Hellwig-Burgel T, Stiehl DP, Wagner AE et al (2005) Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25:297–310
Mole DR, Blancher C, Copley RR et al (2009) Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 284:16767–16775
Moran EM, Heydrich R, Ng CT et al (2011) IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates. PLoS One 6:e24048
Murdoch C, Muthana M, Lewis CE (2005) Hypoxia regulates macrophage functions in inflammation. J Immunol 175:6257–6263
Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5:712–721
Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A (2008) Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 14:5947–5952
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hahne, M., Gaber, T. & Buttgereit, F. Hypoxie als ein Schlüsselfaktor im Entzündungsgebiet bei rheumatischen Erkrankungen. Z. Rheumatol. 71, 64–67 (2012). https://doi.org/10.1007/s00393-011-0782-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-011-0782-x